Drawing on global experience, our panel will deep-dive into the effectiveness & value of vaccines and the taskforce model.
07/02/23 03:00 pm
Led by experts from across the UK’s COVID-19 response, this webinar sets out to answer two vital questions?
High risk and low profits often dictate the return on investment expected from vaccines, but following the COVID-19 pandemic and our strong reliance on effective and efficient vaccinations and their accompanying rollouts, are we missing their true value? And if so, how do we change this?
The COVID-19 Vaccine Task Force model employed in the UK led to one of the most successful vaccine rollouts in the world, ensuring millions received the ‘jab’. Now the UK government plans to use this approach again to tackle four of our most pressing healthcare issues: cancer, obesity, mental health, and addiction, but will it work? And is this really the best model for approaching these critical challenges?
Drawing on experience from across the UK and globally, our panel will deep-dive into these questions, providing examples from the UK’s COVID-19 Vaccine Task Force, the Department of Health and Social Care in England and OHE research on the global socio-economic value of vaccines.
Prof. Lotte Steuten, Deputy Chief Executive – OHE (Chair)
Sir Jonathan Van-Tam, Pro-Vice-Chancellor for the Faculty of Medicine & Health Sciences – University of Nottingham, and Former Deputy Chief Medical Officer for England
Ruth Todd, Chief Commercial Officer – HS2, and Former Programme Director of Vaccines Taskforce
Stuart Carroll, Director of Market Access & Policy – Moderna, and Visiting Fellow – OHE
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!